FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4396311000001106: Cilastatin sodium (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    14699501000001117 Cilastatin sodium (substance) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    14699601000001118 Cilastatin sodium en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Cilastatin sodium Is a Cilastatin false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Imipenem 500mg / Cilastatin 500mg powder for solution for injection vials Has active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection Has active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Has active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Primaxin IV 500mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Imipenem 500mg / Cilastatin 500mg powder for solution for injection vials 1 vial Has active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Has active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Has active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Primaxin IV 500mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) 1 vial Has active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) 1 vial Has active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) 1 vial Has specific active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Primaxin IM 500mg powder for suspension for injection vials (Organon Pharma (UK) Ltd) Has specific active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection Has specific active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Imipenem 500mg / Cilastatin 500mg powder for suspension for injection vials 1 vial Has specific active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Primaxin IV 500mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has specific active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Primaxin IV 500mg powder for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) 1 vial Has specific active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) Has specific active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Imipenem 500mg / Cilastatin 500mg powder for solution for injection vials Has specific active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Primaxin IV 500mg powder for solution for infusion monovials (Organon Pharma (UK) Ltd) 1 vial Has specific active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Imipenem 500mg / Cilastatin 500mg powder for solution for injection vials 1 vial Has specific active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Hospira UK Ltd) Has specific active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials 5 vial Has specific active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Hospira UK Ltd) 5 vial Has specific active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Hospira UK Ltd) 1 vial Has specific active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) Has specific active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials 10 vial Has specific active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Kent Pharma (UK) Ltd) 10 vial Has specific active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) Has specific active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (Actavis UK Ltd) 1 vial Has specific active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) Has specific active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 1 vial Has specific active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier
    Imipenem 500mg / Cilastatin 500mg powder for solution for infusion vials (A A H Pharmaceuticals Ltd) 10 vial Has specific active ingredient False Cilastatin sodium Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start